After a period of travel to visit and meet with R&D Leaders and other pharma representatives, Kerry and Luisa re-group. With conference season well underway, the team run through some key highlights from ASCO and prepare for ADA. Expect details on lung cancer progress (MRK, BMY/BNTX, PFE) and RevMed’s belle of the ball in pancreatic cancer.